Format

Send to

Choose Destination
Gynecol Oncol. 2013 Jan;128(1):6-11. doi: 10.1016/j.ygyno.2012.09.013. Epub 2012 Sep 21.

Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?

Author information

1
University Hospital Leuven, Leuven Cancer Institute, Division of Gynecological Oncology, Department of Obstetrics and Gynecology, Leuven, Belgium European Union. Electronic address: Ignace.vergote@uzleuven.be.
2
Kliniken Essen Mitte, Department of Gynecology & Gynecologic Oncology, Essen, Germany.
3
University Hospital Leuven, Leuven Cancer Institute, Division of Gynecological Oncology, Department of Obstetrics and Gynecology, Leuven, Belgium European Union.
PMID:
23006973
DOI:
10.1016/j.ygyno.2012.09.013
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center